Neuropeutics Inc is a start-up company launched by LMP faculty member and Vice Chair Research (life sciences), Dr. Janice Robertson and recent graduate from the LMP PhD program, Dr. Marc Shenouda. With an aim to tackle neurodegenerative diseases, they have now partnered with medical research charity LifeArc to develop a new drug for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions.
